Cassava Sciences Inc (SAVA)
2.36
+0.07
(+3.06%)
USD |
NASDAQ |
Dec 20, 16:00
2.34
-0.02
(-0.85%)
After-Hours: 20:00
Cassava Sciences Enterprise Value: -35.44M for Dec. 20, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Bristol-Myers Squibb Co | 157.99B |
| BridgeBio Pharma Inc | 6.472B |
| Seelos Therapeutics Inc | 9.932M |
| Alnylam Pharmaceuticals Inc | 29.91B |
| EyePoint Pharmaceuticals Inc | 232.15M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -27.94M |
| Total Expenses (Quarterly) | 30.62M |
| EPS Diluted (Quarterly) | -0.58 |
| Earnings Yield | -58.47% |
| Operating Earnings Yield | 29.46% |
| Normalized Earnings Yield | 201.70 |